The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Gilenyaź (fingolimod) 0.5 mg daily as a disease modifying therapy in patients with highly active relapsing-remitting multiple sclerosis (MS) despite treatment with beta interferon, or in patients with rapidly evolving severe relapsing-remitting MS.
As part of the preparation for the Global Companion Diagnostics Forum IQPC have put together a short survey on Companion Diagnostics issues. The survey takes only a couple of minutes to complete and can be accessed here: http://www.surveymonkey.com/s/CDX
As Turkey, France and California become the first to move to 2D data matrix barcodes on pharmaceutical packaging, Fairfield launch a cost effective scan solution; the only system on the market that can read all three utilised barcodes in one simple scan.
MarketHATCH Patient Acquisition Programs benefit patients, providers,pharmacists and manufacturers. Our coupon and rebate programs are cost effective, easily implemented and impacted. We always have our focus on agreat patient experience.
The Anti-Counterfeiting Trade Agreement (ACTA), a proposed agreement created for the purpose of establishing international standards regarding the enforcement of intellectual property rights, sparked many controversies about the parts relating to the online counterfeiting.
Dr Karl Broich, Vice President, BfArM, will discuss the new regulatory landscape as well as projected amendments to the current guidance documents on CNS clinical trials at Optimising Clinical Development for CNS conference, 15-16 February 2011 in London.
IV Ukrainian practical conference on logistics named "Logistics: Strategic cooperation" took place on 26th of November in Kiev. More than 150 professionals and experts of various logistics branches visited this event.
On December 9 Daya Medicals, Inc. will present its the new dynamic product, the MedPod, to a select group of industry specialists and health care professionals. This will be the first public viewing and demonstration of the product.
CMDBioscience, a CT based biotechnology company specializing in computer-aided peptide drug discovery, announced today the completion of a research collaboration aimed at identifying novel peptide antagonists of the dengue virus using the CMDBioscience proprietary computational peptide drug discovery platform.
Crystal Pharmatech focuses on the specialized field of solid state information for active pharmaceutical ingredients and formulations. Its core services include: salt/polymorph screening, cocrystal screening, chiral resolution, and solid state NMR.
The French Trade Commission UBIFRANCE in London will showcase five innovative companies from the biotechnology and pharmaceutical sectors at the Genesis Conference, which will be held on 9 December 2010 at the Queen Elizabeth II Conference Centre in central London. These French companies are aiming to establish new professional contacts and explore business opportunities between France and the UK.
IN CELL ART, a biotechnology company involved in macromolecular drug (siRNA or DNA) delivery systems, has announced today that the company has entered into a research collaboration agreement with Merial to evaluate IN CELL ART'S nanocarrier technologies in the context of Merial's vaccines programme.
Gateway Analytical will be exhibiting its pharmaceutical testing services at booth number 2801 at the FIP Pharmaceutical Sciences 2010 World Congress in Association with the AAPS Annual Meeting and Exposition.